Ustekinumab and Omalizumab

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Supply)
Duration
2 year (est.)
Value
£14M
Sector
HEALTH
Published
11 Sep 2024
Delivery
To 11 Sep 2026 (est.)
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 8 suppliers

2 buyers

7 suppliers

Description

Supply of Ustekinumab and Omalizumab to NHS Scotland

Lot Division

1 Ustekinumab

Supply of Ustekinumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to a six (6) Framework Participants.

Award Criteria
Quality Criterion: API Source 5.0
PRICE 95.0
2 Omalizumab

Supply of Omalizumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to two (2) Framework Participants.

Award Criteria
API Source 5.0
PRICE 95.0

Award Detail

1 Accord Healthcare (North Harrow)
  • Ustekinumab
  • Num offers: 6
  • Value: £11,680,128 [share]
  • Awarded to group of suppliers.
2 Amgen (Cambridge)
  • Ustekinumab
  • Num offers: 6
  • Value: £11,680,128 [share]
  • Awarded to group of suppliers.
3 Celltrion Healthcare (Slough)
  • Ustekinumab
  • Num offers: 6
  • Value: £11,680,128 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.
4 Janssen Cilag (High Wycombe)
  • Ustekinumab
  • Num offers: 6
  • Value: £11,680,128 [share]
  • Awarded to group of suppliers.
5 Sandoz (Surrey)
  • Ustekinumab
  • Num offers: 6
  • Value: £11,680,128 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.
6 Stada UK Thornton & Ross (Huddersfield)
  • Ustekinumab
  • Num offers: 6
  • Value: £11,680,128 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.
7 Celltrion Healthcare (Slough)
  • Omalizumab
  • Num offers: 2
  • Value: £2,136,450 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.
8 Novartis Pharmaceuticals (London)
  • Omalizumab
  • Num offers: 2
  • Value: £2,136,450 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

(SC Ref:777753)

Reference

Domains